Trustees
Since 31 January 2018, the sole trustee of the Thalidomide Trust has been ‘Thalidomide Trust Company’. The individuals who served as charity trustees before that date now serve as the directors of the trustee company. However, we continue to refer them as trustees internally for continuity and because their role within the Trust remains unchanged. Our current trustees are:
Sir Robert Nelson
Chair of Trustees
Trustee since December 2010
Marlene Winfield OBE
Vice – Chair of Trustees
Trustee since July 2009
Mark Benstead B.A, M.B.A
Trustee since May 2015
Senior fixed income fund manager at Legal and General Investment Management.
David Body
Trustee since January 2015
Until 30th April 2015, David was National Head of the Product Liability Team at Irwin Mitchell and had specialised in medical negligence and product liability work since the mid 1980s.
Professor Tim Briggs, MD(Res), MCh(Ort), FRCS
Medical Trustee
Trustee since July 2015
Professor Caroline Glendinning AcSS
Trustee since June 2007
Professor of Social Policy in the Social Policy Research Unit, University of York since 2004.
John H Howard
Trustee since December 2009
A non-executive director of the Financial Ombudsman Service, National Counties Building Society, and the Gas and Electricity Markets Authority (OFGEM).
Mark Spofforth OBE BSC FCA CTA FRSA
Trustee since December 2013
Senior Partner of Spofforths Chartered Accountants, former President of the Institute of Chartered Accountants.
Kevin R Wesbroom MA MA FIA
Trustee since December 2010
A leading actuary with Aon Hewitt, formerly a Partner in the actuarial firm Bacon and Woodrow.
